Research Article
Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis
Table 1
Clinical characteristics of the LC patients and BLD controls.
| | Parameters | LC () | BLD () | value |
| | Age (year) | | | | | Range | 40-82 | 35-87 | | | Mean (SD) | 61.4 (9.9) | 57.9 (10.6) | 0.164 | | Gender | | | | | Male | 106 | 84 | 0.092 | | Female | 26 | 34 | 0.092 | | Smoking, (%) | | | | | Ever/current | 89 (67.4) | 72 (61.0) | 0.291 | | Never | 43 (32.6) | 46 (39.0) | 0.291 | | Cancer stage, (%) | | Diseases () | | | I | 6 (4.5) | Bronchitis (26) | | | II | 10 (7.6) | CAP (55) | | | III | 47 (35.6) | COPD (8) | | | IV | 69 (52.3) | Bronchiectasis (12) | | | Cancer subtype, (%) | | Pulmonary tuberculosis (6) | | | Adenocarcinoma | 73 (55.2) | Parapneumonic effusion (4) | | | Squamous-cell carcinoma | 29 (22.0) | OSAS (4) | | | Large cell lung carcinoma | 1 (0.8) | CVA (3) | | | SCLC | 29 (22.0) | | |
|
|
SD: standard deviation; LC: lung cancer; SCLC: small cell lung cancer; BLD: benign lung diseases; CAP: community-acquired pneumonia; COPD: chronic obstructive pulmonary disease; CVA: cough variable asthma; OSAHS: obstructive sleep apnea syndrome.
|
